ALPHA, BETA SVVP1 VIRUS CLONE, PRODUCES (VR-2077)

Designation / Description ALPHA, BETA SVVP1 VIRUS CLONE, PRODUCES
U.S. Patent Number
Biosafety Level 2

Biosafety  classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Comments
A recombinant virus which produces SV-40 large T antigen and contains a human alphabeta choriogonadotropin clone.
This encodes both the alpha and beta subunits of human luteinizing hormone and produces both subunits in host mammalian cells in a biologically active, glycosylated heterodimeric form.
The vector is an SV40 deriv with SV40 promoter and pMB1 and SV40 replicons.
The LHA gene is on a HindIII fragment. The LHB gene is on an EcoRI/BamHI fragment.
Shipped frozen
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished.
Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation
References

Reddy VB, et al. Heteropolymeric protein. US Patent 4,840,896 dated Jun 20 1989